ARTICLE
Vol 135 No 1559: 5 August 2022
A comparison of the performance of saliva and nasopharyngeal nucleic acid amplification testing for the detection of SARS-CoV-2 in New Zealand
Gary McAuliffe, Timothy Blackmore, Juliet Elvy, Shivani Fox-Lewis, Brent Gilpin, Jenny Grant, Radhika Nagappan, Erasmus Smit, Chor Ee Tan, Fernalynn Tiongko, James Ussher
Worldwide, molecular detection of SARS-CoV-2 is primarily focussed on swab-based sampling of the nasopharyngeal, nasal, and/or oropharyngeal cavities, but as the pandemic has progressed there has been increasing interest in the role of saliva as a sample type.